Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950712 · ClinicalTrials.gov registry record
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
A clinical trial of Herpes Genitalis, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 537
- Enrollment target
- 20
- Study locations
NCT04950712 is a study of Herpes Genitalis that has completed, run by GlaxoSmithKline. The registered enrollment target is 537 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT04950712, a study of Herpes Genitalis, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 537 participants
- Enrollment target
- 20
- Study locations
Study Summary
The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well as the performance study procedures in a decentralised setting. Ultimately, this study will allow generating additional real-world evidence (RWE) on patterns of recurrences and other key parameters.
Conditions Studied
Interventions
- PROCEDURE Blood sampling
- PROCEDURE Anogenital lesion swab collection
Study Locations (20)
Florida
- GSK Investigational Site - Miami
- GSK Investigational Site - Miami
- GSK Investigational Site - Miami
- GSK Investigational Site - Plantation
California
- GSK Investigational Site - Long Beach
- GSK Investigational Site - Los Angeles
- GSK Investigational Site - San Francisco
Texas
- GSK Investigational Site - Austin
- GSK Investigational Site - Fort Worth
- GSK Investigational Site - Houston
Georgia
- GSK Investigational Site - Marietta
- GSK Investigational Site - Smyrna
Missouri
- GSK Investigational Site - Kansas City
- GSK Investigational Site - St Louis
New Jersey
- GSK Investigational Site - Lawrenceville
- GSK Investigational Site - Newark
Massachusetts
- GSK Investigational Site - Boston
Ohio
- GSK Investigational Site - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 537 participants |
| Start Date | 2021-06-09 |
| Est. Completion | 2024-03-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04950712
The ClinicalTrials.gov registry entry for NCT04950712 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 537 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Herpes Genitalis appearing as the primary indexed condition, and to 2 interventions - of which Blood sampling is the first listed.
NCT04950712 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, Texas.
Frequently Asked Questions
What is clinical trial NCT04950712 about?
NCT04950712 is a clinical study titled "An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.". The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well a...
What is the current status of trial NCT04950712?
This trial is currently completed. The enrollment target is 537 participants. The study started on 2021-06-09. Estimated completion is 2024-03-14.
What conditions does trial NCT04950712 study?
This clinical trial studies the following conditions: Herpes Genitalis.
What interventions are being tested in trial NCT04950712?
The interventions under investigation include: Blood sampling (PROCEDURE), Anogenital lesion swab collection (PROCEDURE).
Who is sponsoring clinical trial NCT04950712?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04950712 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.